Transplant Diagnostics Market Share, Trends & Forecast by 2034

Transplant Diagnostics Market Outlook from 2024 to 2034

The transplant diagnostics market is projected to be worth US$ 4.5 billion in 2024. The market is anticipated to reach US$ 8.5 billion by 2034. The market is further expected to surge at a CAGR of 6.5% during the forecast period 2024 to 2034.

Key Market Trends and Highlights

The rising number of organ transplantation procedures, including kidney, liver, heart, and lung transplants, is expected to drive the demand for transplant diagnostics. The growing prevalence of organ failure and chronic diseases requiring transplantation has been a major factor.

Technological advancements in transplant diagnostics, such as molecular and genetic testing techniques, are expected to enhance the precision and efficiency of compatibility testing. The advancements contribute to better outcomes for transplant patients.
The increasing prevalence of chronic diseases, such as diabetes and kidney disorders, has been a driving factor for the growth of the transplant diagnostics market. The conditions often lead to organ failure, necessitating transplantation.
The growth in the market for immunosuppressive drugs, which are crucial for preventing organ rejection post transplantation, is expected to complement the transplant diagnostics market. The two markets are closely linked, as effective transplant diagnostics help in tailoring immunosuppressive therapies.

Attributes	Key Insights
Transplant Diagnostics Market Estimated Size in 2024	US$ 4.5 billion
Projected Market Value in 2034	US$ 8.5 billion
Value-based CAGR from 2024 to 2034	6.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The scope for transplant diagnostics rose at an 8.1% CAGR between 2019 and 2023. The global market for transplant diagnostics is anticipated to grow at a moderate CAGR of 6.5% from 2024 to 2034.

The market experienced steady growth during the historical period from 2019 to 2023. The rising prevalence of organ failure and chronic diseases driving the demand for organ transplantation procedures is a significant growth driver.

Continuous advancements in transplant diagnostics technologies, including genomics, molecular testing, and precision medicine, contribute to improved diagnostics accuracy and patient outcomes.
Supportive regulatory frameworks and standards that ensure the quality and reliability of transplant diagnostics solutions play a crucial role in market growth.
The persistent shortage of organs globally emphasizes the need for efficient transplant diagnostics to optimize organ utilization and transplantation success.

Looking ahead to the forecast period from 2024 to 2034, the market is expected to witness significant growth. The increasing acceptance and prevalence of living donor transplants contribute to the demand for more compatibility that is sophisticated testing.

The overall growth in healthcare spending, especially in emerging markets, provides a conducive environment for the development and adoption of advanced transplant diagnostics.
The trend towards patient centric approaches in healthcare, including personalized medicine and tailored treatment plans, influences the development of more individualized transplant diagnostics.
The globalization of healthcare, including cross border organ transplants and international collaborations, creates opportunities for standardizing transplant diagnostics on a global scale.

Transplant Diagnostics Market Key Drivers

Supportive government policies and initiatives to increase organ donation and transplantation have a positive impact on the transplant diagnostics market. Efforts to streamline organ allocation systems and promote awareness about organ donation contribute to market growth.

The overall growth in healthcare expenditure, particularly in emerging economies, provides a conducive environment for the development of transplant diagnostics. Improved healthcare infrastructure and accessibility also play a role.
Increasing awareness among healthcare professionals and the public about the importance of transplant diagnostics and organ donation has the potential to drive market growth. Educational campaigns and training programs contribute to this awareness.
The expansion of transplant services in emerging markets creates new opportunities for transplant diagnostics. The demand for advanced diagnostic tools increases, as healthcare infrastructure improves in these regions.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Challenges in the Transplant Diagnostics Market

The persistent shortage of available organs for transplantation remains a significant challenge. The demand for organs often exceeds the supply, leading to a critical imbalance and limiting the number of transplant procedures that can be performed.

Organ transplantation, including the associated diagnostic procedures, can be expensive. The high costs involved in the entire transplantation process, from surgery to post transplant care, can be a barrier, especially in regions with limited healthcare budgets.
Organ transplantation is a complex medical procedure that involves multiple stages, including compatibility testing, surgery, and post transplant care. The complexity of these procedures can limit the number of transplantations performed and increase the risk of complications.
Despite advances in transplant diagnostics, the risk of organ rejection remains a significant concern. Immunological challenges, including graft versus host disease and host versus graft reactions, can affect the success of transplantation.

Country-wise Insights

The below table showcases revenues in terms of the top five countries, spearheaded by Korea and Japan. The countries are expected to lead the market through 2034.

Countries	Forecast CAGRs from 2024 to 2034
The United States	6.8%
China	6.9%
The United Kingdom	7.2%
Japan	7.4%
Korea	8.0%

Increasing Incidence of Chronic Diseases Driving the Market in the United States

The transplant diagnostics market in the United States expected to expand at a CAGR of 6.8% through 2034. The rising incidence of chronic diseases such as diabetes, kidney disorders, and cardiovascular diseases contributes to the demand for organ transplants, subsequently driving the need for transplant diagnostics.

Ongoing advancements in transplant diagnostics technologies, including molecular testing, next generation sequencing, and flow cytometry, enhance the precision and efficiency of compatibility testing.
The shortage of organs available for transplantation and the increasing number of transplant procedures drive the demand for transplant diagnostics in the United States. Efforts to optimize organ allocation contribute to market growth.

Government Support and Initiatives to Accelerate Market Growth in the United Kingdom

The transplant diagnostics market in the United Kingdom is anticipated to expand at a CAGR of 7.2% through 2034. Supportive government policies, funding for research, and initiatives by the National Health Service to enhance organ donation and transplantation outcomes positively impact the transplant diagnostics market.

The well developed healthcare infrastructure in the United Kingdom, coupled with high accessibility to advanced medical technologies, creates a conducive environment for the growth of transplant diagnostics.
Continuous innovations in transplant diagnostics technologies, including improvements in HLA typing methods and genetic testing, contribute to the growth of the market in the country.

Increasing Awareness and Education Processes Spearhead the Market in China

Transplant diagnostics trends in China are taking a turn for the better. A 6.9% CAGR is forecast for the country from 2024 to 2034. Improved awareness among healthcare professionals and the public about the importance of transplant diagnostics in ensuring successful transplantation procedures can drive demand for these services.

The prevalence of autoimmune diseases leading to the need for organ transplants, such as lupus and rheumatoid arthritis, contributes to the demand for transplant diagnostics in China.
The expanding middle class population in China has increased healthcare expenditure, including expenditures on advanced medical procedures such as organ transplantation and related diagnostics.

Prevalence of Autoimmune Diseases Fueling the Market in Japan

The transplant diagnostics market in Japan is poised to expand at a CAGR of 7.4% through 2034. The prevalence of autoimmune diseases leading to the need for organ transplants, such as lupus and rheumatoid arthritis, contributes to the demand for transplant diagnostics in Japan.

Japan has an aging population, and elderly individuals are more susceptible to conditions requiring organ transplants. The demographic trend increases the demand for transplant diagnostics.
Collaborations between diagnostic companies, transplant centers, and research institutions in Japan support the development of innovative transplant diagnostic solutions and foster market expansion.

Emphasis on Personalized Medicine Driving the Demand in Korea

The transplant diagnostics market in Korea is anticipated to expand at a CAGR of 8.0% through 2034. The increasing emphasis on personalized medicine in the country extends to transplant diagnostics, with a focus on tailoring diagnostic approaches to individual patient profiles.

The adoption of telemedicine and digital health solutions in post transplant care and monitoring enhances patient management, contributing to the overall success of transplant procedures.
A growing healthcare expenditure in Korea supports investments in advanced medical technologies, including transplant diagnostics. Increased financial resources contribute to the adoption of state of the art diagnostic tools.

Category-wise Insights

The below table highlights how instruments segment is projected to lead the market in terms of product and service, and is expected to account for a CAGR of 6.3% through 2034. Based on screening type, the pre transplant segment is expected to account for a CAGR of 6.1% through 2034.

Category	CAGR through 2034
Instruments	6.3%
Pre Transplant	6.1%

Instruments Claims High Demand for Transplant Diagnostics

Based on product and service, the instruments segment is expected to continue dominating the transplant diagnostics market. There is a growing need for high throughput screening instruments that can handle a large volume of samples efficiently, as the demand for transplant diagnostics continues to rise, which is particularly important in the context of organ transplantation, where timely and accurate results are critical.

The increasing number of organ and tissue transplant procedures globally contributes directly to the demand for transplant diagnostic instruments. The instruments segment benefits from the expanding market for diagnostic tools used in compatibility testing and pre transplant assessments.
The adoption of next generation sequencing technologies in transplant diagnostics enhances the accuracy and depth of genetic information obtained from donor and recipient samples. The next generation sequencing instruments, capable of processing large amounts of genomic data, are integral to modern transplant diagnostics.

Pre Transplant Segment to Hold High Demand for Transplant Diagnostics

In terms of screening type, the pre transplant segment is expected to continue dominating the transplant diagnostics market. The growing prevalence of organ failure and chronic diseases necessitating organ transplantation contributes directly to the demand for pre transplant screening. The need for comprehensive pre transplant diagnostics increases, as the number of transplant procedures rises.

Ongoing advancements in compatibility testing methods and technologies drive the growth of the pre transplant segment. Improved accuracy and efficiency in assessing the compatibility between donor and recipient contribute to the success of transplant procedures.
Human leukocyte antigen typing is a critical component of pre transplant screening. The increasing recognition of the importance of precise HLA matching for successful transplantation boosts the demand for HLA typing services and technologies.

Competitive Landscape

The transplant diagnostics market is characterized by a dynamic and competitive landscape, driven by the increasing demand for accurate and advanced diagnostic solutions in the field of organ and tissue transplantation. Key players in the market are engaged in strategic initiatives, research and development, and collaborations to gain a competitive edge.

Recent Development

In 2022, Immucor Inc., a prominent player in transfusion and transplantation diagnostics, unveiled two new additions to its transplant diagnostics portfolio, reaffirming its dedication to pioneering advancements in the realm of histocompatibility.

Report Scope

Attribute	Details
Estimated Market Size in 2024	US$ 4.5 billion
Projected Market Valuation in 2034	US$ 8.5 billion
Value-based CAGR 2024 to 2034	6.5%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	Value in US$ billion
Key Regions Covered	North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa
Key Market Segments Covered	Product and Service Screening Type Organ Type Region
Key Countries Profiled	The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel
Key Companies Profiled	Becton Dickinson and Company Bio-Rad Laboratories Inc. Illumina Inc. Immucor Transplant Diagnostics Inc. Thermo Fisher Scientific Inc. CareDx Affymetrix Inc. Linkage Biosciences Abbott Laboratories Inc. BioMérieux S.A. QIAGEN NV

Segmentation Analysis of the Transplant Diagnostics Market

By Product and Service:

Instruments
Reagents and Consumables

By Screening Type:

Pre Transplant
Post-Transplant

By Organ Type:

Kidney
Liver
Heart
Lung
Pancreas

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Frequently Asked Questions

What is the anticipated value of the Transplant Diagnostics market in 2024?

The transplant diagnostics market is projected to reach a valuation of US$ 4.5 billion in 2024.

What is the expected CAGR for the Transplant Diagnostics market until 2034?

The transplant diagnostics industry is set to expand by a CAGR of 6.5% through 2034.

How much valuation is projected for the Transplant Diagnostics market in 2034?

The transplant diagnostics market is forecast to reach US$ 8.5 billion by 2034.

Which country is projected to lead the Transplant Diagnostics market?

Korea is expected to be the top performing market, exhibiting a CAGR of 8.0% through 2034.

Which is the dominant product and service in the Transplant Diagnostics domain?

Instruments segment is preferred, and is expected to account for a CAGR of 6.3% through 2034.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product & Service

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Product & Service, 2019 to 2023

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product & Service, 2024 to 2034

5.3.1. Instruments

5.3.2. Reagents & Consumables

5.4. Y-o-Y Growth Trend Analysis By Product & Service, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product & Service, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Screening Type

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Screening Type, 2019 to 2023

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Screening Type, 2024 to 2034

6.3.1. Pre-Transplant

6.3.2. Post-Transplant

6.4. Y-o-Y Growth Trend Analysis By Screening Type, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Screening Type, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Organ Type

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By Organ Type , 2019 to 2023

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Organ Type , 2024 to 2034

7.3.1. Kidney

7.3.2. Liver

7.3.3. Heart

7.3.4. Lung

7.3.5. Pancreas

7.4. Y-o-Y Growth Trend Analysis By Organ Type , 2019 to 2023

7.5. Absolute $ Opportunity Analysis By Organ Type , 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. South Asia and Pacific

8.3.6. East Asia

8.3.7. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. USA

9.2.1.2. Canada

9.2.2. By Product & Service

9.2.3. By Screening Type

9.2.4. By Organ Type

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product & Service

9.3.3. By Screening Type

9.3.4. By Organ Type

9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product & Service

10.2.3. By Screening Type

10.2.4. By Organ Type

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product & Service

10.3.3. By Screening Type

10.3.4. By Organ Type

10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. UK

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Western Europe

11.2.2. By Product & Service

11.2.3. By Screening Type

11.2.4. By Organ Type

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product & Service

11.3.3. By Screening Type

11.3.4. By Organ Type

11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. Poland

12.2.1.2. Russia

12.2.1.3. Czech Republic

12.2.1.4. Romania

12.2.1.5. Rest of Eastern Europe

12.2.2. By Product & Service

12.2.3. By Screening Type

12.2.4. By Organ Type

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product & Service

12.3.3. By Screening Type

12.3.4. By Organ Type

12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. India

13.2.1.2. Bangladesh

13.2.1.3. Australia

13.2.1.4. New Zealand

13.2.1.5. Rest of South Asia and Pacific

13.2.2. By Product & Service

13.2.3. By Screening Type

13.2.4. By Organ Type

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product & Service

13.3.3. By Screening Type

13.3.4. By Organ Type

13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. China

14.2.1.2. Japan

14.2.1.3. South Korea

14.2.2. By Product & Service

14.2.3. By Screening Type

14.2.4. By Organ Type

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product & Service

14.3.3. By Screening Type

14.3.4. By Organ Type

14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Israel

15.2.1.4. Rest of MEA

15.2.2. By Product & Service

15.2.3. By Screening Type

15.2.4. By Organ Type

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product & Service

15.3.3. By Screening Type

15.3.4. By Organ Type

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. USA

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2022

16.1.2.1. By Product & Service

16.1.2.2. By Screening Type

16.1.2.3. By Organ Type

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2022

16.2.2.1. By Product & Service

16.2.2.2. By Screening Type

16.2.2.3. By Organ Type

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2022

16.3.2.1. By Product & Service

16.3.2.2. By Screening Type

16.3.2.3. By Organ Type

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2022

16.4.2.1. By Product & Service

16.4.2.2. By Screening Type

16.4.2.3. By Organ Type

16.5. Germany

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2022

16.5.2.1. By Product & Service

16.5.2.2. By Screening Type

16.5.2.3. By Organ Type

16.6. UK

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2022

16.6.2.1. By Product & Service

16.6.2.2. By Screening Type

16.6.2.3. By Organ Type

16.7. France

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2022

16.7.2.1. By Product & Service

16.7.2.2. By Screening Type

16.7.2.3. By Organ Type

16.8. Spain

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2022

16.8.2.1. By Product & Service

16.8.2.2. By Screening Type

16.8.2.3. By Organ Type

16.9. Italy

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2022

16.9.2.1. By Product & Service

16.9.2.2. By Screening Type

16.9.2.3. By Organ Type

16.10. Poland

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2022

16.10.2.1. By Product & Service

16.10.2.2. By Screening Type

16.10.2.3. By Organ Type

16.11. Russia

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2022

16.11.2.1. By Product & Service

16.11.2.2. By Screening Type

16.11.2.3. By Organ Type

16.12. Czech Republic

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2022

16.12.2.1. By Product & Service

16.12.2.2. By Screening Type

16.12.2.3. By Organ Type

16.13. Romania

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2022

16.13.2.1. By Product & Service

16.13.2.2. By Screening Type

16.13.2.3. By Organ Type

16.14. India

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2022

16.14.2.1. By Product & Service

16.14.2.2. By Screening Type

16.14.2.3. By Organ Type

16.15. Bangladesh

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2022

16.15.2.1. By Product & Service

16.15.2.2. By Screening Type

16.15.2.3. By Organ Type

16.16. Australia

16.16.1. Pricing Analysis

16.16.2. Market Share Analysis, 2022

16.16.2.1. By Product & Service

16.16.2.2. By Screening Type

16.16.2.3. By Organ Type

16.17. New Zealand

16.17.1. Pricing Analysis

16.17.2. Market Share Analysis, 2022

16.17.2.1. By Product & Service

16.17.2.2. By Screening Type

16.17.2.3. By Organ Type

16.18. China

16.18.1. Pricing Analysis

16.18.2. Market Share Analysis, 2022

16.18.2.1. By Product & Service

16.18.2.2. By Screening Type

16.18.2.3. By Organ Type

16.19. Japan

16.19.1. Pricing Analysis

16.19.2. Market Share Analysis, 2022

16.19.2.1. By Product & Service

16.19.2.2. By Screening Type

16.19.2.3. By Organ Type

16.20. South Korea

16.20.1. Pricing Analysis

16.20.2. Market Share Analysis, 2022

16.20.2.1. By Product & Service

16.20.2.2. By Screening Type

16.20.2.3. By Organ Type

16.21. GCC Countries

16.21.1. Pricing Analysis

16.21.2. Market Share Analysis, 2022

16.21.2.1. By Product & Service

16.21.2.2. By Screening Type

16.21.2.3. By Organ Type

16.22. South Africa

16.22.1. Pricing Analysis

16.22.2. Market Share Analysis, 2022

16.22.2.1. By Product & Service

16.22.2.2. By Screening Type

16.22.2.3. By Organ Type

16.23. Israel

16.23.1. Pricing Analysis

16.23.2. Market Share Analysis, 2022

16.23.2.1. By Product & Service

16.23.2.2. By Screening Type

16.23.2.3. By Organ Type

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product & Service

17.3.3. By Screening Type

17.3.4. By Organ Type

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Becton Dickinson and Company (USA)

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Bio-Rad Laboratories Inc (USA)

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Illumina Inc (USA)

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. Immucor Inc (USA)

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Thermo Fisher Scientific Inc (USA)

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. CareDx (USA)

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. Affymetrix Inc (USA)

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Linkage Biosciences (USA)

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. Abbott Laboratories Inc (USA)

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. BioMérieux S.A. (France)

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

18.1.11. QIAGEN NV (Netherlands)

18.1.11.1. Overview

18.1.11.2. Product Portfolio

18.1.11.3. Profitability by Market Segments

18.1.11.4. Sales Footprint

18.1.11.5. Strategy Overview

18.1.11.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Transplant Diagnostics Market

A Study of the Transplant Diagnostics Market by Instruments and Pre Transplant from 2024 to 2034